FDA Warning Letter Recap, April 2021: Crackdown On Unapproved COVID-19 Diagnostics Continues
The US FDA released five warning letters in April, all addressed to companies selling COVID-19 tests without agency clearance, approval or authorization.
You may also be interested in...
Quality and regulatory officials at the three companies offer tips on supporting the mental health of employees, virtually onboarding new hires, and more in the age of COVID-19.
Jeff Shuren, director of the US FDA’s Center for Devices and Radiological Health, said on 6 May that the agency’s efforts around harmonizing its Quality System Regulation with ISO 13485 are “back on track.”
US FDA device center director Jeff Shuren on 6 May shed a tiny bit of light on the agency’s newly announced – but not defined – Inspectional Affairs Council.